Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

1.4K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.4K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

7.0K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.0K
Disorders of Leukocytes01:27

Disorders of Leukocytes

1.1K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.1K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

617
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
617
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Isolation of functional bacteria guided by PCR-DGGE technology from high temperature petroleum reservoirs].

Huan jing ke xue= Huanjing kexue·2008
Same author

Assessing the spatial extent of breast tumor intrinsic optical contrast using ultrasound and diffuse optical spectroscopy.

Journal of biomedical optics·2008
Same author

alpha4/7-conotoxin Lp1.1 is a novel antagonist of neuronal nicotinic acetylcholine receptors.

Peptides·2008
Same author

[Construction and characterization of avian pathogenic Escherichia coli mutants with iro and/or tsh gene mutation].

Sheng wu gong cheng xue bao = Chinese journal of biotechnology·2008
Same author

[Enhancement of GFP expression by Kozak sequence +4G in HEK293 cells].

Sheng wu gong cheng xue bao = Chinese journal of biotechnology·2008
Same author

Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation.

Arteriosclerosis, thrombosis, and vascular biology·2008

Related Experiment Video

Updated: Aug 28, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

232

Platelet-Acute Leukemia Interactions.

Li Zhang1, Jing Liu1, Xiang Qin1

  • 1Department of Pediatrics (Hematological Oncology), Children Hematological Oncology and Birth Defects Laboratory, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China; Sichuan Clinical Research Center for Birth Defects, Luzhou, Sichuan 646000, China.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|September 19, 2022
PubMed
Summary

Platelets are altered in acute leukemia (AL), impacting patient prognosis and potentially influencing leukemia cell growth. Understanding these platelet changes is crucial for managing AL and improving patient outcomes.

Keywords:
Acute leukemiaDrug resistancePlateletPlatelet functionPlatelet parameters

More Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.2K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.6K

Related Experiment Videos

Last Updated: Aug 28, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

232
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.2K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.6K

Area of Science:

  • Hematology
  • Oncology
  • Cell Biology

Background:

  • Acute leukemia (AL) is a severe blood cancer with high mortality.
  • Platelet count, quality, and function are often compromised in AL patients, necessitating transfusions.
  • Emerging evidence suggests a bidirectional relationship between platelets and AL cells.

Purpose of the Study:

  • To review alterations in platelet parameters (count, MPV, PDW, reticulated platelets) in AL.
  • To explore the causes and prognostic significance of these platelet changes.
  • To discuss the impact of platelets on AL cell proliferation and drug resistance.

Main Methods:

  • Literature review of studies on platelet alterations in acute leukemia.
  • Analysis of changes in platelet count, mean platelet volume (MPV), platelet distribution width (PDW), and platelet function.
  • Examination of the effects of platelets on acute leukemia cell behavior.

Main Results:

  • AL significantly alters platelet count, MPV, PDW, and activation.
  • These platelet changes are linked to bleeding risks and patient prognosis.
  • Platelets can influence acute leukemia cell proliferation and drug resistance.

Conclusions:

  • Platelet abnormalities are a key feature of acute leukemia with prognostic implications.
  • Further research into the platelet-leukemia interaction may reveal novel therapeutic strategies.
  • Understanding platelet dynamics is essential for optimizing acute leukemia treatment.